國家衛生研究院 NHRI:Item 3990099045/9684
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 857842      線上人數 : 838
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/9684


    題名: In vivo and in vitro efficacy of minocycline-based combination therapy for minocycline-resistant Acinetobacter baumannii
    作者: Yang, YS;Lee, Y;Tseng, KC;Huang, WC;Chuang, MF;Kuo, SC;Yang Lauderdale, TL;Chen, TL
    貢獻者: Division of Infectious Diseases
    摘要: Minocycline-based combination therapy has been suggested as a possible choice for the treatment of minocycline-susceptible Acinetobacter baumannii but their use in minocycline-resistant ones is not well established. In this study, we compared the in vitro and in vivo efficacy of minocycline-based combination therapy (with colistin, cefoperazone/sulbactam or meropenem) to colistin in combination with meropenem for the treatment of minocycline-resistant A. baumannii. During 2006-2010, 191 (17.6%) of 1083 A. baumannii complex isolates not susceptible to minocycline from the Taiwan Surveillance of Antimicrobial Resistance program were collected. Four representative A. baumannii resistant to minocycline, amikacin, ampicillin/sulbactam, ceftazidime, ciprofloxacin, cefepime, gentamicin, imipenem, levofloxacin, meropenem, and piperacillin/tazobactam were selected based on their diversity in pulsotype, collection year, healthcare setting origin, and geographic area. All four isolates had tetB and overexpressed adeABC revealed by quantitative reverse transcription PCR. Among all minocycline-based regimens, only combination with colistin produced a fractional inhibitory concentration index comparable to meropenem combined with colistin. Minocycline (4 or 16 mug/mL) in combination with colistin (0.5 mug/mL) also synergistically killed minocycline-resistant isolates in time-kill studies. Minocycline (50 mg/kg) in combination with colistin (10 mg/kg) significantly improved the survival of mice and reduced the number of bacteria present in the lungs of mice compared to monotherapy. However, minocycline-based (16 mug/mL) therapy was not effective at reducing biofilm-associated bacteria at 24 or 48 h compared to colistin (0.5 mug/mL) and meropenem (8 mug/mL). The clinical use of minocycline in combination with colistin for the treatment of minocycline-resistant A. baumannii may warrant further investigation.
    日期: 2016-07
    關聯: Antimicrobial Agents and Chemotherapy. 2016 Jul;60(7):4047-4054.
    Link to: http://dx.doi.org/10.1128/aac.02994-15
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0066-4804&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000378094400022
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84977126028
    顯示於類別:[楊采菱] 期刊論文
    [郭書辰] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PUB27127171.pdf6832KbAdobe PDF685檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋